150 related articles for article (PubMed ID: 12736720)
1. Manumycin inhibits cell proliferation and the Ras signal transduction pathway in human hepatocellular carcinoma cells.
Zhou JM; Zhu XF; Pan QC; Liao DF; Li ZM; Liu ZC
Int J Mol Med; 2003 Jun; 11(6):767-71. PubMed ID: 12736720
[TBL] [Abstract][Full Text] [Related]
2. [Correlation between inhibitory effect of Manumycin on human hepatoma cancer cell HepG2 and Ras signal transduction pathway].
Zhou JM; Pan QC; Yang XP; Liu ZC; Liao DF; Fu LW; Liang YJ
Ai Zheng; 2002 Apr; 21(4):364-8. PubMed ID: 12452012
[TBL] [Abstract][Full Text] [Related]
3. Manumycin A, inhibitor of ras farnesyltransferase, inhibits proliferation and migration of rat vascular smooth muscle cells.
Kouchi H; Nakamura K; Fushimi K; Sakaguchi M; Miyazaki M; Ohe T; Namba M
Biochem Biophys Res Commun; 1999 Nov; 264(3):915-20. PubMed ID: 10544030
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
5. Akt-dependent antiapoptotic action of insulin is sensitive to farnesyltransferase inhibitor.
Park D; Pandey SK; Maksimova E; Kole S; Bernier M
Biochemistry; 2000 Oct; 39(41):12513-21. PubMed ID: 11027130
[TBL] [Abstract][Full Text] [Related]
6. Manumycin and gliotoxin derivative KT7595 block Ras farnesylation and cell growth but do not disturb lamin farnesylation and localization in human tumour cells.
Nagase T; Kawata S; Tamura S; Matsuda Y; Inui Y; Yamasaki E; Ishiguro H; Ito T; Miyagawa J; Mitsui H; Yamamoto K; Kinoshita M; Matsuzawa Y
Br J Cancer; 1997; 76(8):1001-10. PubMed ID: 9376258
[TBL] [Abstract][Full Text] [Related]
7. Manumycin inhibits ras signal transduction pathway and induces apoptosis in COLO320-DM human colon tumour cells.
Di Paolo A; Danesi R; Nardini D; Bocci G; Innocenti F; Fogli S; Barachini S; Marchetti A; Bevilacqua G; Del Tacca M
Br J Cancer; 2000 Feb; 82(4):905-12. PubMed ID: 10732765
[TBL] [Abstract][Full Text] [Related]
8. YC-1-induced cyclooxygenase-2 expression is mediated by cGMP-dependent activations of Ras, phosphoinositide-3-OH-kinase, Akt, and nuclear factor-kappaB in human pulmonary epithelial cells.
Chang MS; Lee WS; Chen BC; Sheu JR; Lin CH
Mol Pharmacol; 2004 Sep; 66(3):561-71. PubMed ID: 15322248
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of heat shock protein 70 in adherent ovarian cancer and mesothelioma following treatment with manumycin, a farnesyl transferase inhibitor.
Hu W; Wu W; Yeung SC; Freedman RS; Kavanagh JJ; Verschraegen CF
Anticancer Res; 2002; 22(2A):665-72. PubMed ID: 12014635
[TBL] [Abstract][Full Text] [Related]
10. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
Graham TE; Pfeiffer JR; Lee RJ; Kusewitt DF; Martinez AM; Foutz T; Wilson BS; Oliver JM
J Immunol; 1998 Dec; 161(12):6733-44. PubMed ID: 9862703
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of growth and invasive activity of human pancreatic cancer cells by a farnesyltransferase inhibitor, manumycin.
Kainuma O; Asano T; Hasegawa M; Kenmochi T; Nakagohri T; Tokoro Y; Isono K
Pancreas; 1997 Nov; 15(4):379-83. PubMed ID: 9361092
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid.
Matsushima-Nishiwaki R; Okuno M; Takano Y; Kojima S; Friedman SL; Moriwaki H
Carcinogenesis; 2003 Aug; 24(8):1353-9. PubMed ID: 12807734
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase A balances the growth factor-induced Ras/ERK signaling.
Pursiheimo JP; Kieksi A; Jalkanen M; Salmivirta M
FEBS Lett; 2002 Jun; 521(1-3):157-64. PubMed ID: 12067709
[TBL] [Abstract][Full Text] [Related]
14. Manumycin induces apoptosis in human hepatocellular carcinoma HepG2 cells.
Zhou JM; Zhu XF; Pan QC; Liao DF; Li ZM; Liu ZC
Int J Mol Med; 2003 Dec; 12(6):955-9. PubMed ID: 14612973
[TBL] [Abstract][Full Text] [Related]
15. ERK1/2-driven and MKP-mediated inhibition of EGF-induced ERK5 signaling in human proximal tubular cells.
Sarközi R; Miller B; Pollack V; Feifel E; Mayer G; Sorokin A; Schramek H
J Cell Physiol; 2007 Apr; 211(1):88-100. PubMed ID: 17131384
[TBL] [Abstract][Full Text] [Related]
16. MKP-1-induced dephosphorylation of extracellular signal-regulated kinase is essential for triggering nitric oxide-induced apoptosis in human breast cancer cell lines: implications in breast cancer.
Pervin S; Singh R; Freije WA; Chaudhuri G
Cancer Res; 2003 Dec; 63(24):8853-60. PubMed ID: 14695202
[TBL] [Abstract][Full Text] [Related]
17. Farnesyltransferase inhibitor, ABT-100, is a potent liver cancer chemopreventive agent.
Carloni V; Vizzutti F; Pantaleo P
Clin Cancer Res; 2005 Jun; 11(11):4266-74. PubMed ID: 15930366
[TBL] [Abstract][Full Text] [Related]
18. [Antitumor and anti-angiogenic effects of manumycin on human hepatocellular carcinoma HepG2 xenografts in nude mice].
Zhou JM; Zhu XF; Liu ZC; Fu LW; Yang XP; Liang YJ; Pan QC
Ai Zheng; 2005 Aug; 24(8):935-9. PubMed ID: 16086869
[TBL] [Abstract][Full Text] [Related]
19. Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras/Raf/ERK1/2 signaling and hnRNP H1 in castration-resistant prostate cancer cells.
Datta A; Kim H; Lal M; McGee L; Johnson A; Moustafa AA; Jones JC; Mondal D; Ferrer M; Abdel-Mageed AB
Cancer Lett; 2017 Nov; 408():73-81. PubMed ID: 28844715
[TBL] [Abstract][Full Text] [Related]
20. Manumycin inhibits farnesyltransferase and induces apoptosis of drug-resistant interleukin 6-producing myeloma cells.
Frassanito MA; Cusmai A; Piccoli C; Dammacco F
Br J Haematol; 2002 Jul; 118(1):157-65. PubMed ID: 12100143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
